Medical and economic analysis of the impact of rheumatoid disease-associated disability on the country's economy in terms of implementation of pension reforms

The paper presents the data of an original study evaluating the impact of disability associated with a number of rheumatic diseases (RDs) (rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis) on the country's economy, as well as their related losses of the state under the conditions of implementation of the upcoming pension reform (PR). The authors consider the socioeconomic importance of disability associated with RDs in the current period and after PR implementation in 2019–2028, determine the degree of its influence on the country's gross domestic product, and also calculate the economic efficiency of return of the potentially able-bodied proportion of disabled people (able-bodied population) to socioeconomic activity.

The opinions of experts and leading experts in this area from different subjects of the Russian Federation were taken into account when preparing the study.

1. Russian spelling dictionary. http://lopatin.academic.ru/

2. Federal state statistics service. URL: http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/population/demography/#

3. Folomeeva OM, Nasonov EL, Andrianova IA. Rheumatoid arthritis in rheumatological care of Russia: the severity of the disease in a russian patient population: a cross-sectional epidemiological study (RAISER). Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2010;48(1):50-60. (In Russ.). doi: 10.14412/1995-4484-2010-1406

4. http://www.lvrach.ru/news/4952193/, http://r-factor.ru/ra.htm

5. Ministry of health of Russian Federation, Department of monitoring, analysis and strategic development of health, FSBI «Central research Institute of organization and Informatization of health» of the Ministry of health of the Russian Federation. Morbidity of the entire population of Russia in 2016. Statistical data. Moscow; 2017.

6. Sieper J, Braun J, Rudwaleit M, et al. Ankylosing spondylitis: an overview. Ann Rheum Dis. 2002 Dec;61 Suppl 3:iii8-18.

7. Ministry of health of Russian Federation. Clinical guidelines. Ankylosing spondylitis (CR 252).

8. Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005 Oct;53(4):573.

9. Olivieri I, Padula A, D’Angelo S, Cutro MS. Psoriatic arthritis sine psoriasis. J Rheumatol Suppl. 2009 Aug;83:28-9. doi: 10.3899/jrheum.090218.

10. Federal'nye klinicheskie rekomendatsii. Dermatovenerologiya 2015: Bolezni kozhi. Infektsii, peredavaemye polovym putem [Dermatology 2015: diseases of the skin. Sexually transmitted infections]. 5th ed. Moscow: Delovoi ekspress; 2016. 768 p.

11. Pincus T, Callahan LF. Reassessment of twelve traditional paradigms concerning the diagnosis, prevalence, morbidity and mortality of rheumatoid arthritis. Scand J Rheumatol Suppl. 1989;79:67-96.

12. Fex E, Larsen BM, Nived K, Eberhardt K. Effect of rheumatoid arthritis on work status and leisure time activities in patients followed 8 years from onset. J Rheumatol. 1998 Jan; 25(1):44-50.

13. Folomeeva OM, Lobareva LS, Ushakova MA. Disability due to rheumatic diseases among residents of the Russian Federation. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2001;39(1):15-21. (In Russ.).

14. Federal state Information system «Federal register of disabled persons». https://sfri.ru/analitika/chislennost/chislennost?territory=1

15. Federal state statistics service. http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/population/disabilities/#

16. Raghunath S, Hijjawi R, Hoon E, et al. Qualitative assessment of medication adherence in patients with rheumatic diseases on biologic therapy. Clin Rheumatol. 2019 Jun 6. doi: 10.1007/s10067-019-04609-y. [Epub ahead of print]

17. Murage MJ, Tongbram V, Feldman SR, et al. Medication adherence and persistence in patients with rheumatoid arthritis, psoriasis, and psoriatic arthritis: a systematic literature review. Patient Prefer Adherence. 2018 Aug 21;12:1483-1503. doi: 10.2147/PPA.S167508. eCollection 2018.

18. Ryabitseva LF. Otsenka priverzhennosti bol'nykh s revmatoidnym artritom k medikamentoznomu lecheniyu [Assessment of adherence of patients with rheumatoid arthritis to medication]. Chelyabinsk; 2009. P. 10-6.

19. Akhunova RR, Yakhin KK, Yakupova SP, Salikhov IG. Adherence of the patients with rheumatoid arthritis to base anti-inflammatory treatment. Klinitsist. 2012;6(1):42-5. (In Russ.).

20. Levitan AI, Reshet'ko OV Assessment of adherence of patients with rheumatoid arthritis to medication. Farmakoekonomika: teoriya i praktika. 2016; 9(1):213. (In Russ.).

21. Lila AM, Dreval' RO, Shipitsyn VV. Assessment of organization of medical care and drug provision for patients with rheumatic diseases, and the socioeconomic burden of these diseases in the Russian Federation. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2018;12(3):112-9. (In Russ.). doi: 10.14412/1996-7012-2018-3-112-119